Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1995 | 09-1995 | 06-1995 | 03-1995 | 12-1994 | |
| Sales | 623,132 | 606,600 | 645,338 | 582,765 | 590,838 |
| Gross Profit | 623,132 | 606,600 | 645,338 | 582,765 | 590,838 |
| Operating Income | 623,132 | 606,600 | 645,338 | 582,765 | 590,838 |
| Pre-tax Income | 623,132 | 606,600 | 645,338 | 582,765 | 590,838 |
| Net Income Continuous | 63,976 | 82,600 | 81,170 | 53,072 | 82,212 |
| Net Income | $63,976 | $82,600 | $81,170 | $53,072 | $82,212 |
| EPS Basic Total Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Basic Continuous Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted Total Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted Continuous Ops | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EBITDA(a) | $623,132 | $606,600 | $645,338 | $582,765 | $590,838 |